Posted from: Wednesday, June 29, 2016 - 11:55 AM - Present


June 1, 2016 – The U.S. Food and Drug Administration (FDA) approved Juvéderm Volbella® XC manufactured by Allergan.  Juvéderm Volbella XC is intended for use in lip augmentation and for correction of perioral lines (lines around the lips) in adults 21 years of age and older. Juvéderm Volbella XC contains a hyaluronic acid gel formulation that is designed to add volume to the lips and soften perioral lines.

Adverse reactions or quality problems experienced with the use of a recalled product may be reported to the FDA’s MedWatch Adverse Event Reporting Program either online, by regular mail or by fax.

Actual drug patent expiration dates and a availability of new medications are subject to change due to patent litigation, settlement agreements, additional patents, exclusivities, and final FDA approval.  Distribution and availability of new medications at pharmacies may not occur immediately following FDA approval.  Patients are advised to speak with their healthcare professional or pharmacist regarding appropriateness as well as actual availability.

*This is provided for information only.  The reference to any medication above does not mean the medication is covered by your plan.

Last Updated Friday, October 18, 2019 - 02:00 AM.